Net loss: UK£2.64m (loss narrowed by 15% from FY 2022). UK£0.11 loss per share (improved from UK£0.14 loss in FY 2022). It's necessary to consider the ever-present spectre of investment risk. We've ...

* NETSCIENTIFIC PLC - RICHARD SYKES WILL RETIRE FROM BOARD FOLLOWING NINE YEARS AS CHAIRMAN 登録するここ. * NETSCIENTIFIC PLC - IAN POSTLETHWAITE WILL RETIRE FROM BOARD AND STEP DOWN AS CEO/CFO * ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

Net loss: UK£3.09m (loss widened by 30% from FY 2021). UK£0.14 loss per share (further deteriorated from UK£0.13 loss in FY 2021). Before we wrap up, we've discovered 6 warning signs for NetScientific ...

Proactive Investors - NetScientific PLC (LON: NSCI), the AIM-listed venture capital and corporate finance firm, has announced significant strategic moves with Martlet Capital, including appointing its ...

(Reuters) - British life sciences company NetScientific Plc said on Monday that one of its subsidiaries has entered an exclusive licensing agreement with AstraZeneca Plc to globally sell a COVID-19 ...

NetScientific hosts Capital Markets Day to outline its strategy and showcase its portfolio of assets London, UK - 14 June 2016 - NetScientific plc (AIM: NSCI), the transatlantic healthcare technology ...

April 27 (Reuters) - Netscientific PLC: * NETSCIENTIFIC PLC - FY LOSS AFTER TAX OF £4.9 MILLION (2018: LOSS £9.4 MILLION) 登録するここ. * NETSCIENTIFIC-DRAWN UP CASH PRESERVATION PLANS IN CASE REVENUE DOES ...

NetScientific enters into an alliance with Healthboxto invest in new early-stage healthcare companies 11 December 2014: NetScientific (AIM:NSCI), the global biomedical and healthcare technology group, ...